Press releases

21 May, 2021
News
IR
Swedish
Corporate Information
Other Corporate Information
Den 25 april 2018 beslutade årsstämman i Ziccum AB (publ) (”Ziccum” eller ”Bolaget”) att emittera 200 000 teckningsoptioner till styrelsens fyra ledamöter inom ramen för ett teckningsoptionsprogram (”LTI...
19 May, 2021
News
IR
English
Corporate Information
Other Corporate Information
Last week saw repeated calls from influential global stakeholders to establish or upgrade vaccine manufacturing facilities, particularly those in low- and middle- income countries (LMICs). Ziccum CEO: “We welcome these important developments and...
14 May, 2021
News
IR
Swedish
Corporate Action
Other
Den 27 april 2021 beslutade årsstämman i Ziccum AB (publ) (”Ziccum” eller ”Bolaget”), efter förslag från styrelsen respektive valberedningen, att anta ett långsiktigt incitamentsprogram för styrelseledamöter...
28 April, 2021
News
IR
English
Corporate Information
Other Corporate Information
Ziccum AB is now integrating the UN’s Sustainable Development Goals (SDGs) into every aspect of its industrial and business strategy. CFO Frida Hjelmberg: “We have identified that our regional Fill and Finish plants formulating thermostable...
27 April, 2021
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Ziccum AB (publ) (”Ziccum”) avhöll den 27 april 2021 årsstämma. Med anledning av rådande covid-19-pandemi hölls årsstämman endast genom poströstning. Vid stämman fattades bland annat följande...
23 April, 2021
News
IR
Swedish
Regulatory
Listing Regulation
Report
Interim
Q1
Sammanfattning av delårsrapporten - första kvartalet 2021 Ziccum har offentligjort sina mål för 2021, huvudmålen är att ingå ett första licensavtal avseende ett eller flera vacciner samt att presentera en detaljerad...
23 April, 2021
News
IR
English
Regulatory
Listing Regulation
Report
Interim
Q1
Summary of interim report, first quarter 2021 Ziccum has announced its goals for 2021, the main goals are to enter into a first licensing agreement for one or more vaccines and to present a detailed plan to establish a production facility for filling...
21 April, 2021
News
IR
English
Corporate Information
Other Corporate Information
Ziccum AB is actively supporting the WHO’s World Immunization Week 2021, this year with the theme ‘Vaccines Bring us Closer’. CEO Göran Conradson: “We’ll be attending meetings and policy events with vaccine bodies from...
19 April, 2021
News
IR
English
Corporate Information
Other Corporate Information
A ground-breaking new memorandum of understanding between CEPI (The Coalition for Epidemic Preparedness Innovations) and the African Union was signed following a prestigious two-day virtual event, attended by Ziccum, hosted by the Africa Centres for Disease...
26 March, 2021
News
IR
English
Corporate Information
Other Corporate Information
Dr Anton Löfgren is an industrial process engineer specialising in unit operations in pharma manufacturing. For four months he visited Ziccum to develop mathematical models of Ziccum’s LaminarPace vaccine air-drying methodology for future industrial...
27 April, 2021
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Ziccum AB (publ) (”Ziccum”) avhöll den 27 april 2021 årsstämma. Med anledning av rådande covid-19-pandemi hölls årsstämman endast genom poströstning. Vid stämman fattades bland annat följande...
23 April, 2021
News
IR
Swedish
Regulatory
Listing Regulation
Report
Interim
Q1
Sammanfattning av delårsrapporten - första kvartalet 2021 Ziccum har offentligjort sina mål för 2021, huvudmålen är att ingå ett första licensavtal avseende ett eller flera vacciner samt att presentera en detaljerad...
23 April, 2021
News
IR
English
Regulatory
Listing Regulation
Report
Interim
Q1
Summary of interim report, first quarter 2021 Ziccum has announced its goals for 2021, the main goals are to enter into a first licensing agreement for one or more vaccines and to present a detailed plan to establish a production facility for filling...
24 March, 2021
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Aktieägarna i Ziccum AB (publ), org.nr 559107-9412, kallas härmed till årsstämma den 27 april 2021. Mot bakgrund av den extraordinära situation som råder till följd av covid-19-pandemin kommer Ziccum AB:s årsstämma...
23 March, 2021
News
IR
English
Regulatory
Listing Regulation
Report
Annual
(Lund, Sweden, 23 March 2021) Ziccum AB today announces that its Annual Report for 2020 is now available on the company’s website. For further information and to read the Full Report (in Swedish) please visit:: https://ziccum.com/investors/financial-reports/...
23 March, 2021
News
IR
Swedish
Regulatory
Listing Regulation
Report
Annual
(Lund, sverige mars 23, 2021) Ziccum AB meddelar att bolagets årsredosvisning för 2020 nu finns tillgänglig på bolagets hemsida. För mer information vänligen besök: https://ziccum.com/investors/financial-reports/ Pressmeddelandet...
11 February, 2021
News
IR
English
Regulatory
Listing Regulation
Report
Interim
Yearend
Summary of year-end report, fourth quarter 2020 During the fourth quarter, Ziccum announced that it had carried out a pilot study on large-scale production of temperature-stable vaccines. The pilot study centred on a Fill and Finish facility (the last...
11 February, 2021
News
IR
Swedish
Regulatory
Listing Regulation
Report
Interim
Yearend
Sammanfattning av delårsrapporten - fjärde kvartalet 2020 Under fjärde kvartalet meddelade Ziccum att en pilotstudie på storskalig produktion av temperaturstabila vacciner har genomförts. Pilotstudien avser en Fill and finish-anläggning...
25 January, 2021
News
IR
English
Regulatory
MAR
Corporate Action
Other
Lund, January 25, 2021 -- Ziccum AB (publ) (‘Ziccum’) entered into an evaluation study agreement on 3 Oct 2019 with Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Based on positive...
25 January, 2021
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
Lund, 25 januari 2021. Ziccum AB (publ) (‘Ziccum’) ingick ett utvärderingsavtal 3 oktober 2019 med Janssen Vaccine & Prevention B.V., en av Janssens läkemedelsbolag som tillhör Johnson & Johnson. Baserat på de...